Total Payments
$54,434
2024 Payments
$291.29
Companies
10
Transactions
41
Medicare Patients
229
Medicare Billing
$26,325
Payment Breakdown by Category
Research$53,139 (97.6%)
Food & Beverage$1,294 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $53,139 | 2 | 97.6% |
| Food and Beverage | $1,294 | 39 | 2.4% |
Payments by Type
Research
$53,139
2 transactions
General
$1,294
39 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $53,139 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $498.23 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $206.69 | 4 | $0 (2018) |
| Novo Nordisk Inc | $174.90 | 4 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $144.66 | 3 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $110.66 | 2 | $0 (2023) |
| ViiV Healthcare Company | $62.55 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $47.12 | 3 | $0 (2018) |
| Harmony Biosciences LLC | $38.41 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $11.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $291.29 | 5 | Novo Nordisk Inc ($174.90) |
| 2023 | $1,823 | 4 | Philips Electronics North America Corporation ($1,624) |
| 2021 | $51,516 | 1 | Philips Electronics North America Corporation ($51,516) |
| 2018 | $442.82 | 13 | GlaxoSmithKline, LLC. ($215.37) |
| 2017 | $360.32 | 18 | GlaxoSmithKline, LLC. ($166.47) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.83 | General |
| 07/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $55.11 | General |
| 07/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $41.85 | General |
| 07/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $55.11 | General |
| 05/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $116.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $62.55 | General |
| Category: HIV | ||||||
| 12/06/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $38.41 | General |
| Category: SLEEP MEDICINE | ||||||
| 07/30/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $98.92 | General |
| Category: Central Nervous System | ||||||
| 02/02/2023 | Philips Electronics North America Corporation | (1305) Mask (Device) | — | Cash or cash equivalent | $1,623.60 | Research |
| Study: SRC_SLE(PI)_Trillium_2021_11345 • Category: Medical Device | ||||||
| 12/16/2021 | Philips Electronics North America Corporation | (2383) SleepUndivided (Device) | — | Cash or cash equivalent | $51,515.62 | Research |
| Study: SRC-SLE(PI)-Trillum-2021-11345 • Category: Medical Device | ||||||
| 10/25/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $64.19 | General |
| Category: Neurology | ||||||
| 07/13/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: RESPIRATORY | ||||||
| 07/06/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $69.88 | General |
| 05/07/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $71.49 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $73.44 | General |
| Category: Neurology | ||||||
| 04/18/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: RESPIRATORY | ||||||
| 03/16/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2018 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Respiratory | ||||||
| 02/09/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: Neurology | ||||||
| 02/07/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SRC-SLE(PI)-Trillum-2021-11345 | Philips Electronics North America Corporation | $51,516 | 1 |
| SRC_SLE(PI)_Trillium_2021_11345 | Philips Electronics North America Corporation | $1,624 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 229 | 248 | $72,160 | $26,325 |
Total Patients
229
Total Services
248
Medicare Billing
$26,325
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 72 | $26,620 | $9,607 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 80 | $21,197 | $7,716 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $15,833 | $5,844 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 17 | $5,826 | $2,240 | 38.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 41 | 44 | $2,684 | $918.48 | 34.2% |
About Dr. Carole Guy, M.D
Dr. Carole Guy, M.D is a Pulmonary Disease healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659318921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carole Guy, M.D has received a total of $54,434 in payments from pharmaceutical and medical device companies, with $291.29 received in 2024. These payments were reported across 41 transactions from 10 companies. The most common payment nature is "" ($53,139).
As a Medicare-enrolled provider, Guy has provided services to 229 Medicare beneficiaries, totaling 248 services with total Medicare billing of $26,325. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Newark, DE
- Active Since 06/02/2006
- Last Updated 03/30/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659318921
Products in Payments
- (2383) SleepUndivided (Device) $51,516
- (1305) Mask (Device) $1,624
- TRELEGY ELLIPTA (Drug) $188.83
- Xyrem (Drug) $144.66
- SPIRIVA RESPIMAT (Drug) $120.96
- NUCALA (Biological) $116.39
- Austedo XR (Drug) $98.92
- BREO (Drug) $79.57
- ANORO ELLIPTA (Drug) $66.67
- APRETUDE (Biological) $62.55
- ANORO (Drug) $46.77
- WAKIX (Drug) $38.41
- UTIBRON (Drug) $34.21
- STIOLTO (Drug) $15.85
- SEEBRI (Drug) $12.91
- QVAR (Drug) $11.74
- SYMBICORT (Drug) $11.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Newark
Richard Miller, M.d, M.D
Pulmonary Disease — Payments: $342,023
Pulmonary Disease $342,023
Albert Rizzo, Md, MD
Pulmonary Disease — Payments: $244,886
Pulmonary Disease $244,886
Dr. Thiruvengadam Anandarangam, Md, MD
Pulmonary Disease — Payments: $38,205
Pulmonary Disease $38,205
Dr. Hemantkumar Patel, Md, MD
Pulmonary Disease — Payments: $19,694
Pulmonary Disease $19,694
Dr. Haroon Raja, Md, MD
Pulmonary Disease — Payments: $17,933
Pulmonary Disease $17,933
Lee Reichman, M.d, M.D
Pulmonary Disease — Payments: $9,755
Pulmonary Disease $9,755